Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Dactolisib (1 RCT; 62 participants)
It is very uncertain whether estimates of effects, ranking, and certainty of evidence for… changes dactolisib (1 RCT; 62 participants) compared with placebo (very low certainty).
2 findings from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyOR 0.56 [0.13, 2.37]1 study · 62 participantsVery low
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyHR 0.55 [0.25, 1.21]1 study · 62 participantsLow